Donisi Health is a MedTech company providing in-home health detection solutions for congestive heart failure (CHF) and chronic-disease patients.
Donisi enables a user-friendly pre-emptive approach to cardiac and pulmonary health monitoring in the home, helping to optimize the continuum of care for patients with CHF and other chronic diseases and avoid unnecessary rehospitalization.
Donisi is helping patients with Congestive Heart Failure (CHF) and other chronic cardiopulmonary diseases, freeing them to focus on living their life to the fullest, by monitoring the patient’s health daily to support timely detection of changes in lung fluid content (indicating heart failure exacerbation) and more, thereby avoiding unnecessary rehospitalization. Based on Donisi’s FDA-cleared technology, and backed by 11 granted patents, Donisi’s contact-free health detection works free from wires, wearables, and patches. Our patented AI-based system detects and analyzes multiple health bio-indicators simultaneously, delivering clinically meaningful insights and notifications of changes in key health indicators. Donisi has the only clinically validated contact-free technology that can remotely detect signs of pulmonary congestion and additional parameters key for heart failure exacerbation detection in the home.
- FDA Clearance: Gili Pro BioSensor
- 11 Granted Patents
- BIRD Grant Recipient - Partnership with Dell Technologies
- Winner, MEDinISRAEL 2021, Startup Innovation Competition
- Winner, Future Unicorn, E&T Innovation
- Winner, Innovations in Cardiac Intervention (ICI), 2021
Filter products by Health System clients